rs1131692053
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP5_Moderate
The NM_005921.2(MAP3K1):c.634-8T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
MAP3K1
NM_005921.2 splice_region, intron
NM_005921.2 splice_region, intron
Scores
2
Splicing: ADA: 0.9999
2
Clinical Significance
Conservation
PhyloP100: 0.652
Genes affected
MAP3K1 (HGNC:6848): (mitogen-activated protein kinase kinase kinase 1) The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-56859707-T-A is Pathogenic according to our data. Variant chr5-56859707-T-A is described in ClinVar as [Pathogenic]. Clinvar id is 30144.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr5-56859707-T-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K1 | NM_005921.2 | c.634-8T>A | splice_region_variant, intron_variant | ENST00000399503.4 | NP_005912.1 | |||
MAP3K1 | XM_047417218.1 | c.634-8T>A | splice_region_variant, intron_variant | XP_047273174.1 | ||||
MAP3K1 | XM_047417219.1 | c.223-8T>A | splice_region_variant, intron_variant | XP_047273175.1 | ||||
MAP3K1 | XM_047417220.1 | c.223-8T>A | splice_region_variant, intron_variant | XP_047273176.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K1 | ENST00000399503.4 | c.634-8T>A | splice_region_variant, intron_variant | 1 | NM_005921.2 | ENSP00000382423.3 | ||||
ENSG00000237705 | ENST00000415589.1 | n.298A>T | non_coding_transcript_exon_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 29
GnomAD4 exome
Cov.:
29
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
46,XY sex reversal 6 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jul 17, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0101 - Gain of function is a known mechanism of disease in this gene and is associated with 46,XY sex reversal 6 (MIM#613762) (PMIDs: 21129722, 24135036, 30608580). (I) 0107 - This gene is associated with autosomal dominant disease. However, it is sex-limited in that only 46XY individuals are affected (GeneReviews). (I) 0115 - Variants in this gene are known to have variable expressivity. Intra- and inter-familial variability have been reported (PMIDs: 27899157, 12476449, 21129722). (I) 0210 - Splice site variant proven to affect splicing of the transcript with a known effect on protein sequence. RNA analysis from affected individuals demonstrated presence of an aberrant transcript containing an insertion of 6bp, predicted to result in p.(Val211_Val212insIleGln) (PMID: 21129722). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0600 - Variant is located in the annotated GEF domain (PMID: 30608580). (I) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. It has been identified in a large multi-generational French family (PMID: 21129722). (SP) 0901 - This variant has strong evidence for segregation with disease. Five heterozygous affected individuals were identified in a large multi-generational family. The other affecteds were not genotyped (PMID: 21129722). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 10, 2010 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 2
DS_AL_spliceai
Position offset: 8
Find out detailed SpliceAI scores and Pangolin per-transcript scores at